JP2015517309A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517309A5 JP2015517309A5 JP2015511761A JP2015511761A JP2015517309A5 JP 2015517309 A5 JP2015517309 A5 JP 2015517309A5 JP 2015511761 A JP2015511761 A JP 2015511761A JP 2015511761 A JP2015511761 A JP 2015511761A JP 2015517309 A5 JP2015517309 A5 JP 2015517309A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- antibody
- multispecific antibody
- multispecific
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645302P | 2012-05-10 | 2012-05-10 | |
| US61/645,302 | 2012-05-10 | ||
| PCT/US2013/040575 WO2013170168A1 (en) | 2012-05-10 | 2013-05-10 | Multi-specific monoclonal antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017246602A Division JP6465953B2 (ja) | 2012-05-10 | 2017-12-22 | 多重特異性モノクローナル抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517309A JP2015517309A (ja) | 2015-06-22 |
| JP2015517309A5 true JP2015517309A5 (enExample) | 2016-07-21 |
| JP6267689B2 JP6267689B2 (ja) | 2018-01-24 |
Family
ID=49551307
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511761A Active JP6267689B2 (ja) | 2012-05-10 | 2013-05-10 | 多重特異性モノクローナル抗体 |
| JP2017246602A Active JP6465953B2 (ja) | 2012-05-10 | 2017-12-22 | 多重特異性モノクローナル抗体 |
| JP2019000631A Active JP6723392B2 (ja) | 2012-05-10 | 2019-01-07 | 多重特異性モノクローナル抗体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017246602A Active JP6465953B2 (ja) | 2012-05-10 | 2017-12-22 | 多重特異性モノクローナル抗体 |
| JP2019000631A Active JP6723392B2 (ja) | 2012-05-10 | 2019-01-07 | 多重特異性モノクローナル抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US9969813B2 (enExample) |
| EP (2) | EP3553089A1 (enExample) |
| JP (3) | JP6267689B2 (enExample) |
| KR (3) | KR102089526B1 (enExample) |
| CN (2) | CN108690132B (enExample) |
| AU (3) | AU2013259276B2 (enExample) |
| CA (3) | CA2872908C (enExample) |
| DK (1) | DK2847231T3 (enExample) |
| ES (1) | ES2749200T3 (enExample) |
| HK (1) | HK1210620A1 (enExample) |
| IN (1) | IN2014DN09417A (enExample) |
| MX (2) | MX2019001355A (enExample) |
| WO (1) | WO2013170168A1 (enExample) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2872908C (en) | 2012-05-10 | 2023-11-14 | Gerhard Frey | Multi-specific monoclonal antibodies |
| EP4610368B1 (en) | 2013-08-05 | 2026-02-04 | Twist Bioscience Corporation | De novo synthesized gene libraries |
| WO2015175375A1 (en) | 2014-05-13 | 2015-11-19 | Short Jay M | Conditionally active biological proteins |
| US11111288B2 (en) | 2014-08-28 | 2021-09-07 | Bioatla, Inc. | Conditionally active chimeric antigen receptors for modified t-cells |
| ES3034398T3 (en) | 2014-08-28 | 2025-08-18 | Bioatla Inc | Conditionally active chimeric antigen receptors for modified t-cells |
| WO2016126882A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| IL258164B (en) | 2015-09-18 | 2022-09-01 | Twist Bioscience Corp | Methods for modulating protein and cellular activity and method for nucleic acid synthesis |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| WO2017123537A1 (en) | 2016-01-12 | 2017-07-20 | Bioatla, Llc | Diagnostics using conditionally active antibodies |
| US10697972B2 (en) | 2016-01-12 | 2020-06-30 | Bioatla, Llc | Diagnostics using conditionally active antibodies |
| CA3016563A1 (en) | 2016-03-21 | 2017-09-28 | Elstar Therapeutics, Inc. | Multispecific and multifunctional molecules and uses thereof |
| EP3455261B1 (en) | 2016-05-13 | 2022-08-03 | BioAtla, Inc. | Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof |
| JP6871364B2 (ja) | 2016-09-21 | 2021-05-12 | ツイスト バイオサイエンス コーポレーション | 核酸に基づくデータ保存 |
| US20200291089A1 (en) | 2017-02-16 | 2020-09-17 | Elstar Therapeutics, Inc. | Multifunctional molecules comprising a trimeric ligand and uses thereof |
| EP4556433A3 (en) | 2017-02-22 | 2025-08-06 | Twist Bioscience Corporation | Nucleic acid based data storage |
| JP7341900B2 (ja) | 2017-03-03 | 2023-09-11 | オブシディアン セラピューティクス， インコーポレイテッド | 免疫療法のためのｃｄ１９組成物及び方法 |
| AU2018226857B2 (en) | 2017-03-03 | 2025-01-02 | Obsidian Therapeutics, Inc. | Compositions and methods for immunotherapy |
| WO2018222901A1 (en) | 2017-05-31 | 2018-12-06 | Elstar Therapeutics, Inc. | Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| CN111566209B (zh) | 2017-06-12 | 2024-08-30 | 特韦斯特生物科学公司 | 无缝核酸装配方法 |
| EP3661555B1 (en) | 2017-08-01 | 2025-04-16 | Ab Therapeutics, Inc. | Bispecific antibodies and uses thereof |
| EP3681906A4 (en) | 2017-09-11 | 2021-06-09 | Twist Bioscience Corporation | GPCR-BINDING PROTEINS AND THEIR SYNTHESIS |
| KR102889470B1 (ko) | 2017-10-20 | 2025-11-21 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| EP4495142A3 (en) | 2017-12-22 | 2025-05-07 | Argenx BVBA | Bispecific antigen binding construct |
| CA3088911A1 (en) | 2018-01-04 | 2019-07-11 | Twist Bioscience Corporation | Dna-based storage device and method for synthesizing polynucleotides using the device |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| GB201802487D0 (en) | 2018-02-15 | 2018-04-04 | Argenx Bvba | Cytokine combination therapy |
| WO2019178362A1 (en) | 2018-03-14 | 2019-09-19 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| WO2019178364A2 (en) | 2018-03-14 | 2019-09-19 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
| WO2019222706A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| US20220403001A1 (en) | 2018-06-12 | 2022-12-22 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
| KR20210009421A (ko) * | 2018-06-14 | 2021-01-26 | 바이오아트라, 엘엘씨 | 다중 특이적 항체 구조체 |
| CA3105448A1 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| KR20210041604A (ko) * | 2018-08-21 | 2021-04-15 | 바이오아트라, 인코퍼레이티드 | pH 선택성을 보이는 조건부 활성 단백질 |
| EP3870600A1 (en) | 2018-10-24 | 2021-09-01 | Obsidian Therapeutics, Inc. | Er tunable protein regulation |
| CA3124980A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| US12463463B2 (en) | 2019-01-28 | 2025-11-04 | Ab Therapeutics, Inc. | Bispecific antibodies and uses thereof |
| EP3927744A1 (en) | 2019-02-21 | 2021-12-29 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to t cell related cancer cells and uses thereof |
| GB2597851B (en) | 2019-02-21 | 2024-05-29 | Marengo Therapeutics Inc | Antibody molecules that bind to NKP30 and uses thereof |
| EP3927746A1 (en) | 2019-02-21 | 2021-12-29 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| EP3927431A1 (en) | 2019-02-21 | 2021-12-29 | Marengo Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| CN114127112A (zh) | 2019-02-21 | 2022-03-01 | 马伦戈治疗公司 | 与t细胞结合的多功能分子及其治疗自身免疫性病症的用途 |
| CN113785057A (zh) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | 用于抗体优化的变异核酸文库 |
| JP2022521551A (ja) | 2019-02-26 | 2022-04-08 | ツイスト バイオサイエンス コーポレーション | Ｇｌｐ１受容体の変異体核酸ライブラリ |
| MX2021010840A (es) | 2019-03-08 | 2022-01-19 | Obsidian Therapeutics Inc | Composiciones de anhidrasa carbónica 2 (ca2) humana y métodos de regulación ajustable. |
| EP3966227A1 (en) | 2019-05-07 | 2022-03-16 | Voyager Therapeutics, Inc. | Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation |
| AU2020298294A1 (en) | 2019-06-21 | 2022-02-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| WO2021046451A1 (en) | 2019-09-06 | 2021-03-11 | Obsidian Therapeutics, Inc. | Compositions and methods for dhfr tunable protein regulation |
| US12091777B2 (en) | 2019-09-23 | 2024-09-17 | Twist Bioscience Corporation | Variant nucleic acid libraries for CRTH2 |
| WO2021061842A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| WO2021084104A1 (en) | 2019-10-30 | 2021-05-06 | Bioinvent International Ab | Tetravalent antibody molecules |
| EP4084823A4 (en) | 2020-01-03 | 2024-05-15 | Marengo Therapeutics, Inc. | ANTI-TCR ANTIBODY MOLECULES AND THEIR USES |
| WO2021138407A2 (en) | 2020-01-03 | 2021-07-08 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to cd33 and uses thereof |
| CA3180321A1 (en) | 2020-04-24 | 2021-10-28 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to t cell related cancer cells and uses thereof |
| JP2023540248A (ja) | 2020-08-26 | 2023-09-22 | マレンゴ・セラピューティクス，インコーポレーテッド | Ｔｒｂｃ１またはｔｒｂｃ２を検出する方法 |
| WO2022046920A2 (en) | 2020-08-26 | 2022-03-03 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
| GB2616128A (en) | 2020-08-26 | 2023-08-30 | Marengo Therapeutics Inc | Antibody molecules that bind to NKp30 and uses thereof |
| US20230374162A1 (en) * | 2020-10-07 | 2023-11-23 | Amgen Inc. | Rational selection of building blocks for the assembly of multispecific antibodies |
| KR20240004462A (ko) | 2021-04-08 | 2024-01-11 | 마렝고 테라퓨틱스, 인크. | Tcr에 결합하는 다기능성 분자 및 이의 용도 |
| WO2023023055A1 (en) | 2021-08-16 | 2023-02-23 | Renagade Therapeutics Management Inc. | Compositions and methods for optimizing tropism of delivery systems for rna |
| CN118317944A (zh) | 2021-09-14 | 2024-07-09 | 雷纳嘉德医疗管理公司 | 非环状脂质及其使用方法 |
| TW202328067A (zh) | 2021-09-14 | 2023-07-16 | 美商雷納嘉德醫療管理公司 | 環狀脂質及其使用方法 |
| WO2023122752A1 (en) | 2021-12-23 | 2023-06-29 | Renagade Therapeutics Management Inc. | Constrained lipids and methods of use thereof |
| AU2023251104A1 (en) | 2022-04-07 | 2024-10-17 | Renagade Therapeutics Management Inc. | Cyclic lipids and lipid nanoparticles (lnp) for the delivery of nucleic acids or peptides for use in vaccinating against infectious agents |
| WO2026011013A1 (en) | 2024-07-02 | 2026-01-08 | Epibiologics, Inc. | Binding agents and uses thereof |
| WO2026050572A2 (en) | 2024-08-29 | 2026-03-05 | Marengo Therapeutics, Inc. | Multifunctional molecules binding to tcr and uses thereof |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4361549A (en) | 1979-04-26 | 1982-11-30 | Ortho Pharmaceutical Corporation | Complement-fixing monoclonal antibody to human T cells, and methods of preparing same |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| DE69233069T2 (de) | 1991-03-15 | 2003-11-27 | Amgen Inc., Thousand Oaks | Pegylation von polypeptiden |
| EP0746609A4 (en) | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
| CA2150116A1 (en) | 1992-11-24 | 1994-06-09 | S. Christopher Bauer | Interleukin-3 (il-3) multiple mutation polypeptides |
| DK0672142T3 (da) | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| GB9225453D0 (en) | 1992-12-04 | 1993-01-27 | Medical Res Council | Binding proteins |
| DE69414870T2 (de) | 1993-09-22 | 1999-05-12 | Medical Research Council, London | Antikoerper mit geaenderter zielrichtung |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6562594B1 (en) | 1999-09-29 | 2003-05-13 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US7011812B1 (en) | 1996-05-03 | 2006-03-14 | Immunomedics, Inc. | Targeted combination immunotherapy of cancer and infectious diseases |
| ATE365562T1 (de) | 1996-05-03 | 2007-07-15 | Immunomedics Inc | Zielgerichtete kombinations-immuntherapie für krebs |
| US5922845A (en) | 1996-07-11 | 1999-07-13 | Medarex, Inc. | Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| US20020062010A1 (en) | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| US7951917B1 (en) | 1997-05-02 | 2011-05-31 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| US20030207346A1 (en) | 1997-05-02 | 2003-11-06 | William R. Arathoon | Method for making multispecific antibodies having heteromultimeric and common components |
| DK0979281T3 (da) | 1997-05-02 | 2005-11-21 | Genentech Inc | Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele |
| WO1999048527A1 (en) * | 1998-03-27 | 1999-09-30 | Genentech, Inc. | Apo-2 ligand-anti-her-2 antibody synergism |
| US7833528B2 (en) | 1998-06-22 | 2010-11-16 | Immunomedics, Inc. | Use of multispecific, non-covalent complexes for targeted delivery of therapeutics |
| EP1351712B1 (en) | 2000-06-20 | 2007-08-01 | Immunomedics, Inc. | Targeted combination immunotherapy of cancer and infectious diseases |
| US6902734B2 (en) * | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
| US8034903B2 (en) | 2000-10-20 | 2011-10-11 | Chugai Seiyaku Kabushiki Kaisha | Degraded TPO agonist antibody |
| US20020168343A1 (en) | 2001-02-14 | 2002-11-14 | Curiel David T. | Combined transductional and transcriptional targeting system for improved gene delivery |
| AU2002233340B2 (en) | 2001-02-19 | 2008-05-22 | Merck Patent Gmbh | Artificial fusion proteins with reduced immunogenicity |
| US20050142539A1 (en) * | 2002-01-14 | 2005-06-30 | William Herman | Targeted ligands |
| ATE428778T1 (de) | 2002-04-26 | 2009-05-15 | Chugai Pharmaceutical Co Ltd | Verfahren zum screening auf agonistische antikörper |
| AU2013200009B2 (en) | 2002-07-18 | 2015-05-07 | Merus N.V. | Recombinant production of mixtures of antibodies |
| PT2314629E (pt) * | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
| JP4477579B2 (ja) * | 2003-01-21 | 2010-06-09 | 中外製薬株式会社 | 抗体の軽鎖スクリーニング方法 |
| US8597911B2 (en) | 2003-06-11 | 2013-12-03 | Chugai Seiyaku Kabushiki Kaisha | Process for producing antibodies |
| US20090191213A9 (en) | 2003-07-02 | 2009-07-30 | Novo Nordisk A/S | Compositions and methods for regulating NK cell activity |
| US7405275B2 (en) * | 2003-09-24 | 2008-07-29 | Millennium Pharmaceuticals, Inc. | Antibodies which bind human CXCR3 |
| GB0329825D0 (en) | 2003-12-23 | 2004-01-28 | Celltech R&D Ltd | Biological products |
| US20050266425A1 (en) * | 2003-12-31 | 2005-12-01 | Vaccinex, Inc. | Methods for producing and identifying multispecific antibodies |
| AU2005313971B2 (en) | 2004-12-08 | 2011-10-13 | Immunomedics, Inc. | Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| WO2006074399A2 (en) | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| KR20130105885A (ko) | 2005-01-05 | 2013-09-26 | 에프-스타 비오테크놀로기쉐 포르슝스 운드 엔트비클룽스게스.엠.베.하. | 상보성 결정부위와 다른 분자의 부위에서 처리된 결합성을 갖는 합성 면역글로불린 영역 |
| TWI671403B (zh) | 2005-03-31 | 2019-09-11 | 中外製藥股份有限公司 | 控制組裝之多肽的製造方法 |
| EP1926752A2 (en) | 2005-09-23 | 2008-06-04 | Walter Reed Army Institute of Research (WRAIR) | Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| AR060040A1 (es) | 2006-03-21 | 2008-05-21 | Genentech Inc | Antagonistas de vefg y de alfa5 beta 1 |
| EP2059533B1 (en) | 2006-08-30 | 2012-11-14 | Genentech, Inc. | Multispecific antibodies |
| GB0620729D0 (en) | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
| DK2158315T3 (en) * | 2007-06-25 | 2016-06-06 | Esbatech Alcon Biomed Res Unit | Methods of modifying antibodies and modified antibodies with improved functional properties |
| WO2009018386A1 (en) | 2007-07-31 | 2009-02-05 | Medimmune, Llc | Multispecific epitope binding proteins and uses thereof |
| US20090130105A1 (en) * | 2007-08-28 | 2009-05-21 | Biogen Idec Ma Inc. | Compositions that bind multiple epitopes of igf-1r |
| TWI547503B (zh) | 2007-09-26 | 2016-09-01 | 建南德克公司 | 抗α5β1抗體、編碼其之核酸、包含其之組合物及其製造及使用方法 |
| EP2113255A1 (en) * | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| RU2653753C1 (ru) | 2008-06-25 | 2018-05-14 | ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи | СТАБИЛЬНЫЕ И РАСТВОРИМЫЕ АНТИТЕЛА, ИНГИБИРУЮЩИЕ TNFα |
| WO2010003118A1 (en) | 2008-07-02 | 2010-01-07 | Trubion Pharmaceuticals, Inc. | Tgf-b antagonist multi-target binding proteins |
| JP2012531885A (ja) | 2008-07-02 | 2012-12-13 | エマージェント プロダクト デベロップメント シアトル， エルエルシー | Ｉｌ６免疫治療剤 |
| WO2010003108A2 (en) | 2008-07-02 | 2010-01-07 | Trubion Pharmaceuticals, Inc. | TNF-α ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| CA2729899A1 (en) * | 2008-07-14 | 2010-01-21 | Fred J. Stevens | Methods for systematic control of protein stability |
| WO2010014629A1 (en) | 2008-07-28 | 2010-02-04 | Trubion Pharmaceuticals, Inc. | Multi-specific binding proteins targeting b cell disorders |
| BRPI0920749A8 (pt) | 2008-10-02 | 2017-12-12 | Emergent Product Dev Seattle | Proteínas de ligação de antagonista multialvo cd86 |
| NZ594665A (en) | 2009-03-20 | 2013-08-30 | Genentech Inc | Bispecific anti-her antibodies |
| PE20120591A1 (es) | 2009-04-02 | 2012-05-23 | Roche Glycart Ag | Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla |
| CA2773515C (en) | 2009-09-29 | 2015-04-28 | Roche Glycart Ag | Bispecific death receptor agonistic antibodies |
| WO2011053937A2 (en) | 2009-10-30 | 2011-05-05 | Bayer Healthcare Llc | Antibody mimetic scaffolds |
| MX2012006406A (es) | 2009-12-04 | 2012-07-25 | Genentech Inc | Anticuerpos multiespecificos, analogos de anticuerpo, composiciones y metodos. |
| SG181952A1 (en) | 2009-12-29 | 2012-07-30 | Emergent Product Dev Seattle | Heterodimer binding proteins and uses thereof |
| US10143186B2 (en) * | 2010-02-08 | 2018-12-04 | Regeneron Pharmaceuticals, Inc. | Common light chain mouse |
| WO2011109726A2 (en) * | 2010-03-05 | 2011-09-09 | Bioatla Llc | Homologous multi-specific antibodies |
| US9637557B2 (en) * | 2010-04-23 | 2017-05-02 | Genentech, Inc. | Production of heteromultimeric proteins |
| CN105924499B (zh) | 2010-07-16 | 2020-09-15 | 生物蛋白有限公司 | 蛋白演化的新方法 |
| RU2608640C2 (ru) | 2010-08-16 | 2017-01-23 | Новиммун С.А. | Способы получения мультиспецифичных и мультивалентных антител |
| JP6013915B2 (ja) | 2010-11-17 | 2016-10-25 | 中外製薬株式会社 | 血液凝固第ｖｉｉｉ因子の機能を代替する機能を有する多重特異性抗原結合分子 |
| ME02734B (me) | 2011-01-14 | 2017-10-20 | Ucb Biopharma Sprl | Antitelo koje vezuje il-17a i il-17f |
| EP2500073A1 (en) | 2011-03-17 | 2012-09-19 | ChromaCon AG | Method for identification and purification of multi-specific polypeptides |
| WO2012158818A2 (en) | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| WO2013003652A1 (en) | 2011-06-28 | 2013-01-03 | Sea Lane Biotechnologies, Llc | Multispecific stacked variable domain binding proteins |
| UA117901C2 (uk) | 2011-07-06 | 2018-10-25 | Ґенмаб Б.В. | Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування |
| EP2543680A1 (en) | 2011-07-07 | 2013-01-09 | Centre National de la Recherche Scientifique | Multispecific mutated antibody Fab fragments |
| CA2849765C (en) | 2011-09-26 | 2021-10-19 | Jn Biosciences Llc | Hybrid constant regions |
| MY171761A (en) | 2012-03-14 | 2019-10-28 | Regeneron Pharma | Multispecific antigen-binding molecules and uses thereof |
| WO2013142255A2 (en) | 2012-03-22 | 2013-09-26 | University Of Miami | Multi-specific binding agents |
| CA2872908C (en) | 2012-05-10 | 2023-11-14 | Gerhard Frey | Multi-specific monoclonal antibodies |
| KR20150013188A (ko) | 2012-05-24 | 2015-02-04 | 에프. 호프만-라 로슈 아게 | 다중특이적 항체 |
| WO2014022592A1 (en) | 2012-08-02 | 2014-02-06 | Jn Biosciences Llc | Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
| KR20140036905A (ko) | 2012-09-18 | 2014-03-26 | 삼성전자주식회사 | 이중특이 항체를 포함하는 단백질 복합체 |
| GB201223276D0 (en) | 2012-12-21 | 2013-02-06 | Ucb Pharma Sa | Antibodies and methods of producing same |
-
2013
- 2013-05-10 CA CA2872908A patent/CA2872908C/en active Active
- 2013-05-10 KR KR1020197017228A patent/KR102089526B1/ko active Active
- 2013-05-10 US US14/399,617 patent/US9969813B2/en active Active
- 2013-05-10 AU AU2013259276A patent/AU2013259276B2/en active Active
- 2013-05-10 EP EP19174963.9A patent/EP3553089A1/en active Pending
- 2013-05-10 CN CN201810258801.6A patent/CN108690132B/zh active Active
- 2013-05-10 KR KR1020197004783A patent/KR102023401B1/ko active Active
- 2013-05-10 MX MX2019001355A patent/MX2019001355A/es unknown
- 2013-05-10 CN CN201380035170.7A patent/CN104583239B/zh active Active
- 2013-05-10 WO PCT/US2013/040575 patent/WO2013170168A1/en not_active Ceased
- 2013-05-10 JP JP2015511761A patent/JP6267689B2/ja active Active
- 2013-05-10 MX MX2014013590A patent/MX362705B/es active IP Right Grant
- 2013-05-10 KR KR1020147033427A patent/KR101951641B1/ko active Active
- 2013-05-10 EP EP13788439.1A patent/EP2847231B1/en active Active
- 2013-05-10 CA CA3202536A patent/CA3202536A1/en active Pending
- 2013-05-10 ES ES13788439T patent/ES2749200T3/es active Active
- 2013-05-10 DK DK13788439.1T patent/DK2847231T3/da active
- 2013-05-10 IN IN9417DEN2014 patent/IN2014DN09417A/en unknown
- 2013-05-10 HK HK15108289.6A patent/HK1210620A1/xx unknown
- 2013-05-10 CA CA3051210A patent/CA3051210A1/en active Pending
-
2017
- 2017-12-22 JP JP2017246602A patent/JP6465953B2/ja active Active
-
2018
- 2018-02-16 AU AU2018201159A patent/AU2018201159B2/en active Active
- 2018-03-23 US US15/934,596 patent/US20180237543A1/en not_active Abandoned
-
2019
- 2019-01-07 JP JP2019000631A patent/JP6723392B2/ja active Active
- 2019-01-31 US US16/264,028 patent/US10696750B2/en active Active
-
2020
- 2020-03-25 AU AU2020202133A patent/AU2020202133B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517309A5 (enExample) | ||
| ES2564635T3 (es) | Anticuerpos anti-IL-6/IL-6R y métodos de uso de los mismos | |
| US12441803B2 (en) | Engineered CD25 polypeptides and uses thereof | |
| JP2009153527A5 (enExample) | ||
| JP6829194B2 (ja) | Ｖｈ−ｖｌドメイン間角度に基づく抗体ヒト化の方法 | |
| PE20200862A1 (es) | Anticuerpos anti-trem2 y metodos relacionados | |
| EA201792584A1 (ru) | Моноклональное антитело к pd-1 и способ его получения | |
| HK1245300A1 (zh) | 靶组织特异性抗原结合分子 | |
| PE20221262A1 (es) | Anticuerpos terapeuticos y sus usos | |
| JP2019500007A5 (enExample) | ||
| RU2013102596A (ru) | МЫШИ, ЭКСПРЕССИРУЮЩИЕ ЛЕГКУЮ ЦЕПЬ С ВАРМАБЕЛЬНОЙ ОБЛАСТЬЮ α-ЧЕЛОВЕКА И КОНСТАНТНОЙ ОБЛАСТЬЮ МЫШИ | |
| JP2014516540A5 (enExample) | ||
| JP2017169559A5 (enExample) | ||
| PE20240218A1 (es) | Anticuerpos madurados por afinidad y humanizados para fcrh5 | |
| JP2017522888A5 (enExample) | ||
| JP2015519055A5 (enExample) | ||
| JP2012533307A5 (enExample) | ||
| RU2014103784A (ru) | Антитело, блокирующее agr2, и его применение | |
| EA201890447A1 (ru) | Гуманизированные антитела к рецептору ccr7 | |
| EA202091569A1 (ru) | Моноклональные антитела и способы их применения | |
| WO2018092907A1 (ja) | エピトープ均質化抗体パネル、ならびにその作製方法および利用 | |
| CN111320693A (zh) | 抗EphA4抗体 | |
| EA202192907A1 (ru) | Моноклональное антитело, которое специфически связывается с gitr | |
| WO2015110114A3 (de) | Hybridom-zelllinie (my-c-cc0c2-259-1 a4) und deren verwendung zur herstellung eines monoklonalen antikörpers gegen das humane, herzspezifische myosin binding protein c (c-protein, mybpc3, cmybp-c oder my-c) | |
| JP2015526071A (ja) | ヒトＧｎＲＨ受容体に対するモノクローナル抗体のヒト化形態 |